Immediate Impact
15 standout
Citing Papers
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
2024 Standout
Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments
2023 Standout
Works of Sabrina Kless being referenced
NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sabrina Kless | 72 | 33 | 12 | 57 | 4 | 73 | |
| M Asuncion Echeveste | 60 | 16 | 12 | 46 | 4 | 73 | |
| Diego Cortese | 80 | 37 | 21 | 58 | 3 | 94 | |
| Pier Ferruccio Ballerini | 73 | 41 | 10 | 93 | 3 | 109 | |
| Anna-Maria Fink | 168 | 71 | 19 | 142 | 2 | 176 | |
| Hagop M. Kantarjian | 48 | 22 | 11 | 23 | 5 | 57 | |
| Lauren Hanson | 41 | 9 | 24 | 34 | 5 | 88 | |
| Zachary A. Hing | 58 | 30 | 40 | 46 | 5 | 99 | |
| Sabrina Leonetti Crescenzi | 167 | 60 | 10 | 146 | 6 | 175 | |
| Yunhang Guo | 37 | 6 | 18 | 29 | 4 | 64 | |
| Moulod R. El-Agnaf | 40 | 19 | 8 | 33 | 4 | 81 |
All Works
Loading papers...